Meharry Medical School
Welcome,         Profile    Billing    Logout  
 2 Trials 
1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Murray, John J
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Recruiting
3
1000
Europe, Canada, US
TAK-279, Placebo, Apremilast
Takeda
Plaque Psoriasis
07/25
06/26

Download Options